999174026	999174026	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
37014858	37014858	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4140184	4140184	CD	B-NP	O
|	|	CC	I-NP	O
5/29/2006	5/29/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
bronchitis	bronchitis	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
excaerbation	excaerbation	NN	I-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/7/2006	5/7/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/19/2006	11/19/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
TREMBATH	TREMBATH	NNP	B-NP	O
,	,	,	O	O
DEWITT	DEWITT	NNP	B-NP	O
JARRETT	JARRETT	NNP	I-NP	O
257-52-04-2	257-52-04-2	CD	I-NP	O
Caviklus	Caviklus	NNP	I-NP	O
Rd	Rd	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/29/06	1/29/06	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HULCY	HULCY	NNP	B-NP	O
,	,	,	O	O
DAN	DAN	NNP	B-NP	O
OMER	OMER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q2H	Q2H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Shortness	Shortness	NN	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
FOSAMAX	FOSAMAX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALENDRONATE	ALENDRONATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
35	35	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
8	8	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
plain	plain	JJ	B-NP	O
water	water	NN	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/18/06	10/18/06	CD	B-NP	O
by	by	IN	B-PP	O
VOVAK	VOVAK	NNP	B-NP	B-protein
,	,	,	O	O
ROBERTO	ROBERTO	NNP	B-NP	O
L.	L.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
029524696	029524696	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/18/06	10/18/06	CD	B-NP	O
by	by	IN	B-PP	O
BONGIVENGO	BONGIVENGO	NNP	B-NP	O
,	,	,	O	O
STEWART	STEWART	NNP	B-NP	O
OMER	OMER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TIAZAC	TIAZAC	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
831314951	831314951	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATENOLOL	ATENOLOL	NNP	B-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
LIPITOR	LIPITOR	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
WELLBUTRIN	WELLBUTRIN	NNP	I-NP	I-protein
SR	SR	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
BUPROPION	BUPROPION	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
SUSTAINED	SUSTAINED	VBD	B-VP	I-protein
RELEAS	RELEAS	NNP	B-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	NNP	B-NP	I-protein
100	100	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
CALTRATE	CALTRATE	NNP	I-NP	O
600	600	CD	I-NP	O
+	+	SYM	I-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	B-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
BID	BID	NN	I-NP	I-DNA
CARDIZEM	CARDIZEM	NN	I-NP	I-DNA
CD	CD	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
DILTIAZEM	DILTIAZEM	NN	I-NP	I-DNA
CD	CD	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
120	120	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/29/06	1/29/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATENOLOL	ATENOLOL	NNP	B-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
FLOVENT	FLOVENT	NN	B-NP	B-protein
HFA	HFA	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FLUTICASONE	FLUTICASONE	NN	I-NP	I-protein
PROPIONATE	PROPIONATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
110	110	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
FOLATE	FOLATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FOLIC	FOLIC	NNP	I-NP	I-protein
ACID	ACID	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
HUMULIN	HUMULIN	NNP	I-NP	I-protein
N	N	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
750	750	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q48H	Q48H	NN	I-NP	O
X	X	NN	I-NP	O
2	2	CD	I-NP	O
Days	Days	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/5	10/5	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
be	be	VB	I-VP	O
completed	complete	VBN	I-VP	O
by	by	IN	B-PP	O
11/23	11/23	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/18/06	10/18/06	CD	B-NP	O
by	by	IN	B-PP	O
BATTUELLO	BATTUELLO	NNP	B-NP	O
,	,	,	O	O
DELMAR	DELMAR	NNP	B-NP	O
S.	S.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
029524696	029524696	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/18/06	10/18/06	CD	B-NP	O
by	by	IN	B-PP	O
BOWERIZE	BOWERIZE	NNP	B-NP	O
,	,	,	O	O
EVAN	EVAN	NNP	B-NP	O
C.	C.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
672206288	672206288	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	B-protein
PROTONIX	PROTONIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	I-protein
40	40	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
24	24	CD	I-NP	I-protein
h	h	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
dose	dose	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Give	Give	VB	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Starting	Start	VBG	B-VP	O
Today	Today	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/5	10/5	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
AVANDIA	AVANDIA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ROSIGLITAZONE	ROSIGLITAZONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MICONAZOLE	MICONAZOLE	NN	I-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Brian	Brian	NNP	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
-	-	HYPH	B-NP	O
please	please	NN	I-NP	O
call	call	NN	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
4/3/06	4/3/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
5	5	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
ANSMAN	ANSMAN	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
-	-	HYPH	O	O
Dr.	Dr.	NNP	B-NP	O
Nathan	Nathan	NNP	I-NP	O
Merzig	Merzig	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
brochitis	brochitis	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
bronchitis	bronchitis	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
excaerbation	excaerbation	NN	I-NP	O
,	,	,	O	O
DVT	DVT	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
NIDDM	NIDDM	NNP	I-NP	O
OBESIY	OBESIY	NNP	I-NP	O
HTN	HTN	NN	I-NP	O
SPANISH-SPEAKING	SPANISH-SPEAKING	NN	I-NP	O
ONLY	ONLY	NN	I-NP	O
PSORIASIS	PSORIASIS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SEVERE	SEVERE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
high	high	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
cholesterol	cholesterol	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
pelvic	pelvic	JJ	I-NP	O
abcess	abcess	NN	I-NP	O
requiring	require	VBG	B-VP	O
ileostomy	ileostomy	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
abscess	abscess	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diverticultis	diverticultis	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ECHO	ECHO	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
x	x	SYM	O	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
****	****	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
67F	67F	NN	B-NP	O
with	with	IN	B-PP	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
H/O	H/O	NN	B-NP	B-protein
DVT	DVT	NN	I-NP	I-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
AF	AF	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
admitted	admit	VBD	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
x	x	SYM	O	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
c/o	c/o	VBP	B-VP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
dry	dry	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
fleeting	fleeting	JJ	B-NP	B-protein
pleuritic	pleuritic	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
off	off	RB	B-ADVP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
re-anastamosis	re-anastamosis	NN	I-NP	O
of	of	IN	B-PP	O
ileum/colon	ileum/colon	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
a	a	DT	B-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
weeks	week	NNS	B-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
at	at	IN	B-PP	O
1.8-1	1.8-1	CD	B-NP	O
.9	.9	CD	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
c/o	c/o	NN	I-NP	O
left	leave	VBD	B-VP	O
leg	leg	NN	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
N/V/D	N/V/D	NN	I-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
levoflox	levoflox	NN	B-NP	O
,	,	,	O	O
nebulizers	nebulizer	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
prednisone	prednisone	NN	B-NP	O
60mg	60mg	NN	I-NP	O
.	.	.	O	O

****	****	SYM	O	O
HOME	HOME	NN	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
tiazac	tiazac	NN	B-NP	O
120	120	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
flovent	flovent	NN	B-NP	O
110	110	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
4mg	4mg	NN	I-NP	O
M/F	M/F	NN	I-NP	O
,	,	,	O	O
2mg	2mg	NN	B-NP	O
T/WED/TH	T/WED/TH	NN	I-NP	O
/	/	SYM	B-VP	O
SAT/SUN	SAT/SUN	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	B-DNA
81	81	CD	I-NP	I-DNA
,	,	,	O	O
avandia	avandia	NN	B-NP	O
4	4	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
wellbutrin	wellbutrin	NN	B-NP	O
100	100	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
caltrate	caltrate	NN	B-NP	O
D	D	NNP	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
QD	QD	NNP	B-NP	O
,	,	,	O	O
fosamax	fosamax	NN	B-NP	B-protein
35	35	CD	I-NP	I-protein
QWk	QWk	NNP	I-NP	I-protein
,	,	,	O	O
NPH	NPH	NNP	B-NP	O
13U	13U	NNP	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
10	10	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
protonix	protonix	NN	B-NP	O
40	40	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
Kdur	Kdur	VBP	B-VP	O
20	20	CD	B-NP	O
QD	QD	NN	I-NP	O
****	****	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
****	****	SYM	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	SYM	O	O
T	T	NN	B-NP	O
100.1	100.1	CD	I-NP	O
P103	P103	NN	I-NP	O
BP	BP	NN	I-NP	O
172/84	172/84	CD	B-NP	O
RR26	RR26	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
3L	3L	NN	I-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
PT	PT	NN	B-NP	O
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
AAOx3	AAOx3	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
NC/AT	NC/AT	NN	B-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
PULM	PULM	NN	B-NP	O
:	:	:	O	O
diffuse	diffuse	JJ	B-NP	O
wheezing	wheezing	NN	I-NP	O
and	and	CC	I-NP	O
rhonchi	rhonchi	NN	I-NP	O
CVS	CVS	NN	I-NP	O
:	:	:	O	O
nl	nl	NN	B-NP	B-protein
s1s2	s1s2	NN	I-NP	I-protein
,	,	,	O	O
irregularly	irregularly	RB	B-NP	O
irregular	irregular	JJ	I-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-ADJP	O
,	,	,	O	O
staples	staple	NNS	B-NP	O
at	at	IN	B-PP	O
ostomy	ostomy	NN	B-NP	O
site	site	NN	I-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
LLE	LLE	NN	B-NP	O
>	>	SYM	B-NP	O
RLE	RLE	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
SKIN	SKIN	NN	I-NP	O
:	:	:	O	O
multiple	multiple	JJ	B-NP	O
psoriatic	psoriatic	JJ	I-NP	O
plagues	plague	NNS	I-NP	O
all	all	DT	B-ADVP	O
over	over	IN	B-PP	O
body	body	NN	B-NP	O
****	****	SYM	I-NP	O
LABS	LABS	NN	I-NP	B-protein
:	:	:	O	O
Cr	Cr	NN	B-NP	O
1.7	1.7	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
15.5	15.5	CD	I-NP	I-cell_line
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
312	312	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	O
2.7	2.7	CD	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
AF	AF	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
vascular	vascular	JJ	B-NP	O
engorgement	engorgement	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
VQ	VQ	NN	I-NP	O
scan	scan	NN	I-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
probablilty	probablilty	NN	I-NP	O
LENI	LENI	NN	I-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
LLE	LLE	NN	I-NP	O
DVT	DVT	NN	I-NP	O
****	****	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
67F	67F	NN	B-NP	O
with	with	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
bronchospam	bronchospam	NN	B-NP	O
x	x	SYM	B-VP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
likely	likely	JJ	I-NP	O
bronchitis	bronchitis	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
LLE	LLE	NN	B-NP	O
DVT	DVT	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
Duoneb	Duoneb	NN	B-NP	O
ATC	ATC	NN	I-NP	O
and	and	CC	O	O
prn	prn	NN	B-NP	O
.	.	.	O	O

Prednsione	Prednsione	NN	B-NP	O
60	60	CD	I-NP	O
QD	QD	NN	I-NP	O
and	and	CC	I-NP	O
taper	taper	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

Levoflox	Levoflox	NN	B-NP	O
x	x	NN	I-NP	O
5days	5day	NNS	I-NP	O
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
flovent	flovent	NN	I-NP	O
*	*	SYM	O	O
VASC	VASC	NNP	B-NP	O
:	:	:	O	O
LLE	LLE	NN	B-NP	O
DVT	DVT	NN	I-NP	O
found	find	VBN	B-VP	O
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
coumadin	coumadin	NN	I-NP	O
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

Low	Low	JJ	B-NP	O
prob	prob	NN	I-NP	O
PE	PE	NN	I-NP	O
per	per	IN	B-PP	O
VQ	VQ	NN	B-NP	O
scan	scan	NN	I-NP	O
*	*	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
Cont	Cont	NNP	B-NP	O
atenolol	atenolol	NN	I-NP	O
,	,	,	O	O
tiazac	tiazac	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
elevated	elevated	JJ	B-NP	O
PAP	PAP	NN	I-NP	O
and	and	CC	O	O
R	R	NN	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
MAT	MAT	NN	B-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
magnesium	magnesium	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

May	May	MD	O	O
need	need	VBP	B-VP	O
IV	IV	CD	B-NP	O
dilt	dilt	NN	I-NP	O
if	if	IN	B-SBAR	O
has	have	VBZ	B-VP	O
further	further	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
tachycardia	tachycardia	NN	B-NP	O
.	.	.	O	O

*	*	SYM	O	O
DM	DM	NN	B-NP	O
:	:	SYM	O	O
NPH	NPH	NN	B-NP	O
25u	25u	NN	I-NP	O
BID	BID	NN	I-NP	O
and	and	CC	O	O
novolg	novolg	NN	B-NP	O
10u	10u	CD	I-NP	O
QAC	QAC	NN	I-NP	O
per	per	IN	B-PP	O
insulin	insulin	NN	B-NP	O
protocol	protocol	NN	I-NP	O
.	.	.	O	O

Check	Check	NN	B-NP	O
AIC	AIC	NN	I-NP	O
*	*	SYM	B-NP	O
ENDO	ENDO	NN	I-NP	O
:	:	:	O	O
TSH	TSH	NN	B-NP	B-DNA
0.1	0.1	CD	I-NP	I-DNA
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
h/o	h/o	NN	B-NP	O
multinodular	multinodular	JJ	I-NP	O
goiter	goiter	NN	I-NP	O
.	.	.	O	O

Free	Free	JJ	B-NP	O
T4	T4	NN	I-NP	O
1.5	1.5	CD	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
PROPH	PROPH	NN	I-NP	O
:	:	:	O	O
coumadin/PPI	coumadin/PPI	NN	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
3.8	3.8	CD	I-NP	I-protein
,	,	,	O	O
so	so	RB	B-NP	O
coumadin	coumadin	NN	I-NP	O
held	hold	VBD	B-VP	O
***************	***************	SYM	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
antiobiotics	antiobiotic	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
inhaled	inhale	VBD	B-VP	O
bronchodilators	bronchodilator	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
quickly	quickly	RB	B-ADVP	O
and	and	CC	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
her	her	PRP$	B-NP	O
SaO2	SaO2	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
was	be	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
left	leave	VBN	I-VP	O
leg	leg	NN	B-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
.	.	.	O	O

LENNI	LENNI	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
DVT	DVT	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
SH	SH	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

**	**	SYM	O	O
On	On	IN	B-PP	O
11/14	11/14	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
feeling	feel	VBG	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
for	for	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
check	check	NN	I-NP	I-protein
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
and	and	CC	O	O
cardiorespiratory	cardiorespiratory	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
call	call	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Zietlow	Zietlow	NNP	I-NP	O
Monday	Monday	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Villerreal	Villerreal	NNP	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WICKE	WICKE	NNP	B-NP	O
,	,	,	O	O
EUGENE	EUGENE	NNP	B-NP	O
RUDY	RUDY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PA423	PA423	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/29/06	1/29/06	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

